Login / Signup

Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria.

Giorgio CasaburiRebbeca M DuarDaniel P VanceRyan MitchellLindsey ContrerasSteven A FreseJennifer T SmilowitzSteven Alex Frese
Published in: Antimicrobial resistance and infection control (2019)
This clinical trial was registered at ClinicalTrials.gov, NCT02457338.
Keyphrases
  • early life
  • clinical trial
  • antibiotic resistance genes
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial
  • wastewater treatment
  • microbial community